Literature DB >> 21165538

Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.

S Krüger1, F M Mottaghy, A K Buck, S Maschke, H Kley, D Frechen, T Wibmer, S N Reske, S Pauls.   

Abstract

UNLABELLED: FDG-PET/CT is increasingly used in staging of lung cancer as single "one stop shop" method. AIM, PATIENTS,
METHODS: We prospectively included 104 neurological asymptomatic patients (65 years, 26% women) with primary diagnosis of lung cancer. In all patients PET/CT including cerebral imaging and cerebral MRI were performed.
RESULTS: Diagnosis of brain metastases (BM) was made by PET/CT in 8 patients only (7.7%), by MRI in 22 (21.2%). In 80 patients both PET/CT and MRI showed no BM. In 6 patients (5.8%) BM were detectable on PET/CT as well as on MRI. Exclusive diagnosis of BM by MRI with negative finding on PET/CT was present in 16 patients (15.4%). 2 patients (1.9%) had findings typical for BM on PET/CT but were negative on MRI. With MRI overall 100 BM were detected, with PET/CT only 17 BM (p < 0.01). For the diagnosis of BM PET/CT showed a sensitivity of 27.3%, specificity of 97.6%, positive predictive value of 75% and negative predictive value of 83.3%. BM diameter on PET/CT and MRI were consistent in 43%, in 57% BM were measured larger on MRI. DISCUSSION: Compared to the gold standard of MRI for cerebral staging a considerable number of patients are falsely diagnosed as free from BM by PET/CT. MRI is more accurate than PET/CT for detecting multiple and smaller BM.
CONCLUSION: In patients with a curative option MRI should be performed additionally to PET/CT for definitive exclusion of brain metastases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165538     DOI: 10.3413/Nukmed-0338-10-07

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  25 in total

Review 1.  Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.

Authors:  Jawad Fares; Deepak Kanojia; Aida Rashidi; Atique U Ahmed; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Clin Breast Cancer       Date:  2019-06-05       Impact factor: 3.225

Review 2.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

3.  Eye-witnessing cancer-an ever-challenging experience.

Authors:  S Jurja
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

4.  Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases.

Authors:  Kung-Chu Ho; Cheng-Hong Toh; Shih-Hong Li; Chien-Ying Liu; Cheng-Ta Yang; Yu-Jen Lu; Tzu-Pei Su; Chih-Wei Wang; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-11-10       Impact factor: 9.236

5.  Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.

Authors:  Zhoulei Li; Ken Herrmann; Sabine Pirsig; Kathrin Philipp-Abbrederis; Martin Henninger; Michaela Aichler; Annette Feuchtinger; Axel Walch; Ambros J Beer; Ingo Ringshausen; Kelsey L Pomykala; Klemens Scheidhauer; Markus Schwaiger; Ulrich Keller; Andreas K Buck
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

6.  Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features.

Authors:  P M Mostardi; F E Diehn; J B Rykken; L J Eckel; K M Schwartz; T J Kaufmann; C P Wood; J T Wald; C H Hunt
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

7.  PET imaging in patients with brain metastasis-report of the RANO/PET group.

Authors:  Norbert Galldiks; Karl-Josef Langen; Nathalie L Albert; Marc Chamberlain; Riccardo Soffietti; Michelle M Kim; Ian Law; Emilie Le Rhun; Susan Chang; Julian Schwarting; Stephanie E Combs; Matthias Preusser; Peter Forsyth; Whitney Pope; Michael Weller; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

8.  Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

Authors:  Jianwei Gao; Lei Li; Xia Liu; Rui Guo; Bin Zhao
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

9.  Molecular MRI enables early and sensitive detection of brain metastases.

Authors:  Sébastien Serres; Manuel Sarmiento Soto; Alastair Hamilton; Martina A McAteer; W Shawn Carbonell; Matthew D Robson; Olaf Ansorge; Alexandre Khrapitchev; Claire Bristow; Lukxmi Balathasan; Thomas Weissensteiner; Daniel C Anthony; Robin P Choudhury; Ruth J Muschel; Nicola R Sibson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 10.  Brain metastases: An update on the multi-disciplinary approach of clinical management.

Authors:  D K Mitchell; H J Kwon; P A Kubica; W X Huff; R O'Regan; M Dey
Journal:  Neurochirurgie       Date:  2021-04-14       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.